Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2023

Nov 21, 2023

32093_dirs_2023-11-20_6f02e2fc-68d4-4710-8517-84cb0067d819.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-11-17

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-17 Common Stock P 241 $6.10 Acquired 36246797 Direct
2023-11-17 Common Stock P 10000 $6.09 Acquired 36256797 Direct
2023-11-17 Common Stock P 10000 $6.11 Acquired 36266797 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 492069 Indirect

Footnotes

F1: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.